GlaxoSmithKline plc

Pharmaceuticals

Company Summary

GlaxoSmithKline plc, through its subsidiaries, develops, manufactures, and markets pharmaceuticals, vaccines, over-the-counter medicines, and health-related consumer items in the United Kingdom, the United States, and globally. Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare are the company's four segments. GlaxoSmithKline plc is based in Brentford, United Kingdom, and was founded in 1715.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

21
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E2S12.4G6.9

Refinitiv

Overall ESG Rating :

93
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E84S96G94

Overall ESG Rating :

AA
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

GSK is a leader among 86 companies in the pharmaceuticals industry.

Temperature Rise :

1.3℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned